Melatonin for Sleep: The American Academy of Sleep Medicine recommends AGAINST using melatonin for chronic insomnia in adults
The 2017 American Academy of Sleep Medicine (AASM) clinical practice guideline explicitly recommends that clinicians NOT use melatonin as a treatment for sleep onset or sleep maintenance insomnia in adults 1. This recommendation is based on trials using 2 mg doses and reflects low quality evidence showing that benefits approximately equal harms.
Context Matters: When Melatonin May Be Appropriate
The key distinction is that melatonin is NOT recommended for typical insomnia, but it has a role in circadian rhythm disorders:
For Delayed Sleep-Wake Phase Disorder (DSWPD)
- Adults with DSWPD: Use 5 mg taken between 19:00-21:00 (7-9 PM) for 28 days 2
- Timing is critical: Administer 1.5-2 hours before desired bedtime, NOT 30 minutes before as commonly practiced
For Children and Adolescents with DSWPD
- Without comorbidities: 0.15 mg/kg (mean dose ~4.4 mg) taken 1.5-2 hours before bedtime 2
- With psychiatric comorbidities (e.g., ADHD): 3-5 mg based on weight (3 mg if <40 kg; 5 mg if >40 kg) at 18:00-19:00 2
What Recent Research Shows (But Guidelines Don't Endorse)
While the AASM guidelines are definitive, newer research suggests potential optimization strategies that contradict current practice:
- A 2024 meta-analysis found 4 mg administered 3 hours before bedtime may be more effective than the typical 2 mg given 30 minutes before sleep 3
- A 2022 study in older adults showed 5 mg significantly increased sleep efficiency during both day and night, primarily by extending Stage 2 NREM sleep 4
However, these findings have not been incorporated into official guidelines, and the AASM's negative recommendation for insomnia remains the standard of care.
Critical Pitfalls to Avoid
Wrong indication: Melatonin is for circadian rhythm disorders, not primary insomnia. For insomnia, consider FDA-approved options like eszopiclone (2-3 mg), zolpidem (10 mg), or doxepin (3-6 mg) 1
Wrong timing: Most people take melatonin 30 minutes before bed—evidence suggests 1.5-3 hours before is more effective for circadian effects 2, 3
Wrong dose: Over-the-counter products often contain 3-10 mg, but evidence for insomnia used 2 mg (which failed to show benefit). For circadian disorders, 4-5 mg appears optimal 2, 3
Lack of regulation: Melatonin is not FDA-approved, leading to variable product quality and dosing 5, 6
Clinical Algorithm
Step 1: Determine if this is insomnia or a circadian rhythm disorder
- Insomnia = difficulty falling/staying asleep with adequate sleep opportunity
- DSWPD = consistent delay in sleep-wake timing (e.g., can't fall asleep until 2-3 AM)
Step 2: If insomnia → Do NOT use melatonin 1
- First-line: Cognitive behavioral therapy for insomnia (CBT-I)
- Pharmacologic options: Eszopiclone, zolpidem, doxepin, or suvorexant
Step 3: If DSWPD → Consider melatonin
- Adults: 5 mg at 19:00-21:00
- Children: 0.15 mg/kg or 3-5 mg (weight-based) at 18:00-19:00
- Duration: Minimum 4 weeks for effect
Step 4: Monitor for adverse effects
- Generally mild (headache, dizziness, nausea)
- Long-term safety data in children/adolescents is lacking 2
- No evidence of dependence or withdrawal 6, 7
The Bottom Line
For typical insomnia in adults, melatonin is not recommended based on the highest quality guideline evidence 1. The evidence shows it doesn't work better than placebo for this indication. If you're considering melatonin, first confirm the patient has a circadian rhythm disorder rather than insomnia, then use appropriate dosing (4-5 mg) and timing (1.5-3 hours before desired sleep time), not the typical over-the-counter approach of 2-3 mg taken 30 minutes before bed.